| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |